Pages that link to "Q48643059"
Jump to navigation
Jump to search
The following pages link to A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis (Q48643059):
Displaying 50 items.
- A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis (Q22241932) (← links)
- Update in vitamin D and multiple sclerosis (Q26780466) (← links)
- Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes (Q26824192) (← links)
- Vitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of Supplementation (Q27011804) (← links)
- Vitamin D and immunity (Q28087758) (← links)
- Vitamin D as a clinical biomarker in multiple sclerosis (Q28287015) (← links)
- Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology (Q28299160) (← links)
- Multiple sclerosis: Pathology, diagnosis and treatments (Q33745006) (← links)
- How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms (Q33988240) (← links)
- Molecular mechanism underlying the impact of vitamin D on disease activity of MS. (Q34268651) (← links)
- Effects of vitamin D in the elderly population: current status and perspectives (Q34274418) (← links)
- Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. (Q34550631) (← links)
- Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis (Q34593669) (← links)
- The influence of nutritional factors on the prognosis of multiple sclerosis (Q34643392) (← links)
- Influence of Diet in Multiple Sclerosis: A Systematic Review. (Q34681985) (← links)
- Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties (Q34773501) (← links)
- Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis (Q35737941) (← links)
- The initiation and prevention of multiple sclerosis (Q35741861) (← links)
- Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial. (Q35745304) (← links)
- Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up (Q36045080) (← links)
- A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment (Q36167453) (← links)
- Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program (Q36169584) (← links)
- Influence of drugs on vitamin D and calcium metabolism (Q36187610) (← links)
- Effect of vitamin D on MS activity by disease-modifying therapy class (Q36242310) (← links)
- Calcitriol modulates the CD46 pathway in T cells (Q36353718) (← links)
- Effect of high-dose vitamin D3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report (Q36396585) (← links)
- Can we prevent or treat multiple sclerosis by individualised vitamin D supply? (Q36588696) (← links)
- Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis (Q36638670) (← links)
- Improving outcomes in multiple sclerosis through early diagnosis and effective management (Q36643255) (← links)
- Vitamin D Supplementation Modulates T Cell-Mediated Immunity in Humans: Results from a Randomized Control Trial (Q36935388) (← links)
- Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis (Q36975701) (← links)
- Vitamin D and immune function (Q37083785) (← links)
- Association of vitamin D status and clinical and radiological outcomes in a treated MS population in Poland (Q37653508) (← links)
- Vitamin D as an early predictor of multiple sclerosis activity and progression (Q37723877) (← links)
- Vitamin D and multiple sclerosis: a critical review and recommendations on treatment (Q38024285) (← links)
- Vitamin D in multiple sclerosis: implications for assessment and treatment (Q38049627) (← links)
- Subcutaneous IFN-β1a to treat relapsing-remitting multiple sclerosis (Q38058831) (← links)
- Treatment optimization in MS: Canadian MS Working Group updated recommendations. (Q38100519) (← links)
- The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis (Q38108689) (← links)
- Disease modification in multiple sclerosis: an update (Q38150823) (← links)
- Environmental factors in multiple sclerosis (Q38167388) (← links)
- Vitamin D and multiple sclerosis: where do we go from here? (Q38169777) (← links)
- Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (Q38194076) (← links)
- Role of vitamin D in acquired immune and autoimmune diseases (Q38210581) (← links)
- Modifiable environmental factors in multiple sclerosis (Q38269727) (← links)
- The role of epidemiology in MS research: Past successes, current challenges and future potential (Q38376270) (← links)
- Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis (Q38387302) (← links)
- Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity. (Q38614976) (← links)
- Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop (Q38663577) (← links)
- Illuminating vitamin D effects on B cells--the multiple sclerosis perspective (Q38682352) (← links)